Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the European Union Drugs Agency (EUDA).
Notes:
Spain: 2002 data. Estonia: 2005 data. France and Luxembourg: self-reported test results.
The 'total' sample sizes were 124 337 males and 20 640 females (all tested with a valid test result in the countries on graph).
Bars show the weighted average of all available studies. Only countries where prevalence was over 2 % were included.
See also 'General notes for interpreting data' on the Explanatory notes and help page.
Sources:
Reitox national focal points. For Estonian data see reference 4 in the Table INF-0.